You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address